M&T Bank’s Zenas BioPharma ZBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-62,622
Closed -$512K 1702
2024
Q4
$512K Buy
62,622
+37,738
+152% +$589K ﹤0.01% 1157
2024
Q3
$422K Buy
+24,884
New +$447K ﹤0.01% 1223

Other funds holding ZBIO

M&T Bank's ZBIO Position: Q1 2025 in Review

M&T Bank sold out of Zenas BioPharma (ZBIO) in Q1 2025, closing a stake of 62,622 shares — an estimated $512K sold.

M&T Bank first reported a position in ZBIO in Q3 2024 and held it in 2 quarters. The position peaked at $512K in Q4 2024. 67 funds tracked by Wall St. Rank hold ZBIO as of Q1 2025.

  • M&T Bank reported no remaining Zenas BioPharma position as of Q1 2025 after selling out during the quarter.
  • M&T Bank sold 62,622 Zenas BioPharma shares in Q1 2025, an estimated $512K.
  • M&T Bank first reported a position in Zenas BioPharma in Q3 2024 and held it in 2 quarters.
  • M&T Bank's Zenas BioPharma position peaked at $512K in Q4 2024.
  • 67 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2025.

Based on M&T Bank's 13F filing for Q1 2025, filed 30 Apr 2025.